7
THCmax (a.k.a. Total THC) = d9-THC + ( THC-A * 0.877 ) CBDmax (a.k.a. Total CBD) = CBD + ( CBD-A * 0.877 ) Total Cannabinoid is a raw sum of all measured cannabinoids In Traceability, Total Cannabinoid is a sum of THCmax and CBDmax Figures may differ slightly from traceability due to rounding ND = Not Detected NE = Not Examined Unk = Unknown 2020-11-22 12:32 Analytical Methods Used Cannabinoids: HPLC-UV Microbial: Plate Counting Terpenes: HS-GC-FID Solvents: HS-GC-MS Trace Residue: UHPLC-MSMS Water Activity: HYGROMER® Page 1 of 2 Official Test Results for Laboratory Sample # 7111625 Origination: Apothecary Rx UBI #: N/A Inventory #: 20201120RB003 Strain: Galactic Haze CBD License #: N/A QA #: 20201120RB003 Type: Flower Harvest Date: Unknown Approved By: T. Sasaki, Ph.D., CSO Address:4920 Atlanta Highway Date of Receipt: 2020-11-20 Alpharetta, GA 30004 Date of Testing: 2020-11-22 S. Stevens, LDR PASS/FAIL [This section intentionally left blank.] Cannabinoid Profile (units of measure are by weight) THC max 0.738% 7.38mg/g CBD max 17.4% 174mg/g % mg/g % mg/g THCA 0.764 7.64 d9-THC 0.0678 0.678 CBDA 19.4 194 CBD 0.361 3.61 CBGA 0.417 4.17 CBG 0.0708 0.708 CBC 0.0619 0.619 CBN ND ND THCVA ND ND THCV ND ND CBDVA 0.164 1.64 CBDV ND ND CBT ND ND d8-THC ND ND Total Cannabinoids (raw sum): 21.3%, 213mg/g 100 10 1 0.1 0.01 d9- THC CBD CBG CBC CBN THCV d8- THC CBDV CBT Shelf Stability Loss-On-Drying NE Water Activity: NE Terpene Fingerprint (units in percent by weight) 10 1 0.1 0.01 0.001 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 T ref# Name % 5 Myrcene 0.65 36 Caryophyllene 0.57 37 Humulene 0.22 2 a-Pinene 0.14 50 Bisabolol 0.1 12 Limonene 0.076 40* a-Bulnesene 0.07 21 Linalool 0.067 6 b-Pinene 0.055 43* b-Maaliene 0.055 ref# Name % 45* a-Maaliene 0.033 15 b-Ocimene 0.032 49* Eudesmol 0.028 44* Selinadiene 0.027 34* trans-a-Bergamotene 0.026 51 trans-Nerolidol 0.023 35 Farnesene 0.021 28 Terpineol 0.018 23 Fenchol 0.013 30* Geraniol 0.011 ref# Name % 24* trans-2-Pinanol 0.011 3 Camphene 0.0038 42 cis-Nerolidol 0.0037 47* Guaiol 0.0033 22 Fenchone 0.0023 7 a-Phellandrene 0.002 8 Carene 0.0019 19 Terpinolene 0.0013 20* p-Cymenene 0.0011 17 Eucalyptol 0.00082 ref# Name % 11 a-Ocimene 0.00079 1* Thujene 0.00054 18 g-Terpinene 0.00048 10 a-Terpinene 0.0003 T Total 2.3 Most Volatile Least Volatile *Semi-quantitative results. These testing results are certified by scientific examination of a single sample provided by the Producer/Processor. Confidence Analytics and its agents did not observe or participate in the sample selection process, and cannot confirm the authenticity of the sample or its representativeness of the associated lot/batch. The sample, as received, was homogenized before subsamples were drawn for specific analyses. This report is supplemental to any other reports with the same analytic sample number. Pass/Fail criteria are defined in WAC 314-55-102. .738 17.4 .437 .0619 .164 43% MONO TERPENES 6% MONO TERPENOIDS 44% SESQUI TERPENES 7% SESQUI TERPENOIDS

Official Test Results for Laboratory Sample # 7111625

  • Upload
    others

  • View
    14

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Official Test Results for Laboratory Sample # 7111625

THCmax (a.k.a. Total THC) = d9-THC + ( THC-A * 0.877 )CBDmax (a.k.a. Total CBD) = CBD + ( CBD-A * 0.877 )

Total Cannabinoid is a raw sum of all measured cannabinoidsIn Traceability, Total Cannabinoid is a sum of THCmax and CBDmax

Figures may differ slightly from traceability due to rounding

ND = Not DetectedNE = Not Examined

Unk = Unknown

2020-11-22 12:32

Analytical Methods UsedCannabinoids: HPLC-UV

Microbial: Plate CountingTerpenes: HS-GC-FIDSolvents: HS-GC-MS

Trace Residue: UHPLC-MSMSWater Activity: HYGROMER®

Page 1 of 2

Official Test Results for Laboratory Sample # 7111625Origination: Apothecary Rx UBI #: N/A Inventory #: 20201120RB003

Strain: Galactic Haze CBD License #: N/A QA #: 20201120RB003Type: Flower Harvest Date: Unknown

Approved By: T. Sasaki, Ph.D., CSOAddress:4920 Atlanta Highway Date of Receipt: 2020-11-20

Alpharetta, GA 30004 Date of Testing: 2020-11-22 S. Stevens, LDR

PASS/FAIL

[This section intentionally leftblank.]

Cannabinoid Profile (units of measure are by weight)THC max0.738%

7.38mg/g

CBD max17.4%

174mg/g% mg/g % mg/g

THCA 0.764 7.64 d9-THC 0.0678 0.678CBDA 19.4 194 CBD 0.361 3.61CBGA 0.417 4.17 CBG 0.0708 0.708CBC 0.0619 0.619 CBN ND NDTHCVA ND ND THCV ND NDCBDVA 0.164 1.64 CBDV ND NDCBT ND ND d8-THC ND ND

Total Cannabinoids (raw sum): 21.3%, 213mg/g

100

10

1

0.1

0.01d9-THC

CBD CBG CBC CBN THCV d8-THC

CBDV CBT

Shelf Stability

Loss-On-Drying NEWater Activity: NE

Terpene Fingerprint (units in percent by weight)10

1

0.1

0.01

0.0011 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 T

ref# Name %5 Myrcene 0.6536 Caryophyllene 0.5737 Humulene 0.222 a-Pinene 0.1450 Bisabolol 0.112 Limonene 0.07640* a-Bulnesene 0.0721 Linalool 0.0676 b-Pinene 0.05543* b-Maaliene 0.055

ref# Name %45* a-Maaliene 0.03315 b-Ocimene 0.03249* Eudesmol 0.02844* Selinadiene 0.02734* trans-a-Bergamotene 0.02651 trans-Nerolidol 0.02335 Farnesene 0.02128 Terpineol 0.01823 Fenchol 0.01330* Geraniol 0.011

ref# Name %24* trans-2-Pinanol 0.0113 Camphene 0.003842 cis-Nerolidol 0.003747* Guaiol 0.003322 Fenchone 0.00237 a-Phellandrene 0.0028 Carene 0.001919 Terpinolene 0.001320* p-Cymenene 0.001117 Eucalyptol 0.00082

ref# Name %11 a-Ocimene 0.000791* Thujene 0.0005418 g-Terpinene 0.0004810 a-Terpinene 0.0003T Total 2.3

Most Volatile Least Volatile *Semi-quantitative results.

These testing results are certified by scientific examination of a single sample provided by the Producer/Processor. Confidence Analytics and its agents did not observe or participate in the sampleselection process, and cannot confirm the authenticity of the sample or its representativeness of the associated lot/batch. The sample, as received, was homogenized before subsamples were drawn for

specific analyses. This report is supplemental to any other reports with the same analytic sample number. Pass/Fail criteria are defined in WAC 314-55-102.

.738

17.4

.437

.0619

.164

43%MONO

TERPENES

6%MONO

TERPENOIDS

44%SESQUI

TERPENES

7%SESQUI

TERPENOIDS

Page 2: Official Test Results for Laboratory Sample # 7111625

THCmax (a.k.a. Total THC) = d9-THC + ( THC-A * 0.877 )CBDmax (a.k.a. Total CBD) = CBD + ( CBD-A * 0.877 )

Total Cannabinoid is a raw sum of all measured cannabinoidsIn Traceability, Total Cannabinoid is a sum of THCmax and CBDmax

Figures may differ slightly from traceability due to rounding

ND = Not DetectedNE = Not Examined

Unk = Unknown

2020-11-22 12:32

Analytical Methods UsedCannabinoids: HPLC-UV

Microbial: Plate CountingTerpenes: HS-GC-FIDSolvents: HS-GC-MS

Trace Residue: UHPLC-MSMSWater Activity: HYGROMER®

Page 2 of 2

Official Test Results for Laboratory Sample # 7111625Origination: Apothecary Rx UBI #: N/A Inventory #: 20201120RB003

Strain: Galactic Haze CBD License #: N/A QA #: 20201120RB003Type: Flower Harvest Date: Unknown

Approved By: T. Sasaki, Ph.D., CSOAddress:4920 Atlanta Highway Date of Receipt: 2020-11-20

Alpharetta, GA 30004 Date of Testing: 2020-11-22 S. Stevens, LDR

Quantitative Impurities Report

Concentrations of analytes used to determine pass/fail status of individual tests.

* Greater than lower limit of detection (>LLOD) and less than lower limit of quantification (<LLOQ) . Applies to instances when theanalyte has been detected and positively identified, but the concentration is lower than we can accurately quantify. Literally: signalto noise ratio greater than 3 and signal less than calibration. LLOD is ~0.001 ppm for most analytes, LLOQ is ~0.01 for mostanalytes. Number shown is lower end of calibration (LLOQ).

** Greater than upper limit of quantification (>ULOQ). Applies to instances when the analyte concentration in the sample is greaterthan we can accurately measure without additional testing. Number shown is upper end of calibration (ULOQ).

These testing results are certified by scientific examination of a single sample provided by the Producer/Processor. Confidence Analytics and its agents did not observe or participate in the sampleselection process, and cannot confirm the authenticity of the sample or its representativeness of the associated lot/batch. The sample, as received, was homogenized before subsamples were drawn for

specific analyses. This report is supplemental to any other reports with the same analytic sample number. Pass/Fail criteria are defined in WAC 314-55-102.

Page 3: Official Test Results for Laboratory Sample # 7111625

THCmax(a.k.a.TotalTHC)=d9-THC+(THC-A*0.877)CBDmax(a.k.a.TotalCBD)=CBD+(CBD-A*0.877)

TotalCannabinoidisarawsumofallmeasuredcannabinoidsInTraceability,TotalCannabinoidisasumofTHCmaxandCBDmax

Figuresmaydifferslightlyfromtraceabilityduetorounding

ND=NotDetectedNE=NotExamined

Unk=Unknown

AnalyticalMethodsUsedCannabinoids:HPLC-UVMicrobial:PlateCountingTerpenes:HS-GC-FIDSolvents:HS-GC-MS

TraceResidue:UHPLC-MSMS

WaterActivity:HYGROMER®Page1of4

OfficialTestResultsforLaboratorySample#8012382Origination:Apothecary Rx UBI#: Inventory#: 210123BS001

Strain: GalacticHaze License#: QA#: 210123BS001Type: Flower HarvestDate: Unknown

ApprovedBy: N.Mosely,CEOAddress:4920 Atlanta Highway DateofReceipt: 2021-01-23

Alpharetta, GA 30004 DateofTesting: 2021-01-23 S. Stevens,LDR

PASS/FAILForeignMatter+Seeds PASS

LossOnDrying(Moisture) NEWaterActivity NE

Microbiological NEMycotoxins PASSPesticides PASS

ChemicalProfile(unitsinpercentbyweight)

CANNABINOIDSNOTEXAMINED

CANNABINOIDSNOTEXAMINED

ShelfStability

Loss-On-Drying NEWaterActivity: NE

ThesetestingresultsarecertifiedbyscientificexaminationofasinglesampleprovidedbytheProducer/Processor.ConfidenceAnalyticsanditsagentsdidnotobserveorparticipateinthesampleselectionprocess,andcannotconfirmtheauthenticityofthesampleoritsrepresentativenessoftheassociatedlot/batch.Thesample,asreceived,washomogenizedbeforesubsamples

weredrawnforspecificanalyses.Thisreportissupplementaltoanyotherreportswiththesameanalyticsamplenumber.Pass/FailcriteriaaredefinedinWAC314-55-102.

Page 4: Official Test Results for Laboratory Sample # 7111625

THCmax(a.k.a.TotalTHC)=d9-THC+(THC-A*0.877)CBDmax(a.k.a.TotalCBD)=CBD+(CBD-A*0.877)

TotalCannabinoidisarawsumofallmeasuredcannabinoidsInTraceability,TotalCannabinoidisasumofTHCmaxandCBDmax

Figuresmaydifferslightlyfromtraceabilityduetorounding

ND=NotDetectedNE=NotExamined

Unk=Unknown

AnalyticalMethodsUsedCannabinoids:HPLC-UVMicrobial:PlateCountingTerpenes:HS-GC-FIDSolvents:HS-GC-MS

TraceResidue:UHPLC-MSMS

WaterActivity:HYGROMER®Page2of4

OfficialTestResultsforLaboratorySample#8012382Origination:Apothecary Rx UBI#: Inventory#: 210123BS001

Strain: GalacticHaze License#: QA#: 210123BS001Type: Flower HarvestDate: Unknown

ApprovedBy: N.Mosely,CEOAddress:4920 Atlanta Highway DateofReceipt: 2021-01-23

Alpharetta, GA 30004 DateofTesting: 2021-01-23 S. Stevens,LDR

QuantitativeImpuritiesReport

Concentrationsofanalytesusedtodeterminepass/failstatusofindividualtests.

* Greaterthanlowerlimitofdetection(>LLOD)andlessthanlowerlimitofquantification(<LLOQ).Appliestoinstanceswhentheanalytehasbeendetectedandpositivelyidentified,buttheconcentrationislowerthanwecanaccuratelyquantify.Literally:signaltonoiseratiogreaterthan3andsignallessthancalibration.LLODis~0.001ppmformostanalytes,LLOQis~0.01formostanalytes.Numbershownislowerendofcalibration(LLOQ).

**Greaterthanupperlimitofquantification(>ULOQ).Appliestoinstanceswhentheanalyteconcentrationinthesampleisgreaterthanwecanaccuratelymeasurewithoutadditionaltesting.Numbershownisupperendofcalibration(ULOQ).

Findings

ALKANESNOTEXAMINED

ALCOHOLSNOTEXAMINED

SOLVENTIMPURITIESNOTEXAMINED

MYCOTOXINSAnalyte Concentration ActionLevel*AflatoxinB1 <LLOQ 20ppbAflatoxinB2 <LLOQ 20ppbAflatoxinG1 <LLOQ 20ppbAflatoxinG2 <LLOQ 20ppbOchratoxinA <LLOQ 20ppb*ActionLevelisSumofAflatoxins

MICROBIOLOGICALSNOTEXAMINED

ThesetestingresultsarecertifiedbyscientificexaminationofasinglesampleprovidedbytheProducer/Processor.ConfidenceAnalyticsanditsagentsdidnotobserveorparticipateinthesampleselectionprocess,andcannotconfirmtheauthenticityofthesampleoritsrepresentativenessoftheassociatedlot/batch.Thesample,asreceived,washomogenizedbeforesubsamples

weredrawnforspecificanalyses.Thisreportissupplementaltoanyotherreportswiththesameanalyticsamplenumber.

Page 5: Official Test Results for Laboratory Sample # 7111625

THCmax(a.k.a.TotalTHC)=d9-THC+(THC-A*0.877)CBDmax(a.k.a.TotalCBD)=CBD+(CBD-A*0.877)

TotalCannabinoidisarawsumofallmeasuredcannabinoidsInTraceability,TotalCannabinoidisasumofTHCmaxandCBDmax

Figuresmaydifferslightlyfromtraceabilityduetorounding

ND=NotDetectedNE=NotExamined

Unk=Unknown

AnalyticalMethodsUsedCannabinoids:HPLC-UVMicrobial:PlateCountingTerpenes:HS-GC-FIDSolvents:HS-GC-MS

TraceResidue:UHPLC-MSMS

WaterActivity:HYGROMER®Page3of4

OfficialTestResultsforLaboratorySample#8012382Origination:Apothecary Rx UBI#: Inventory#: 210123BS001

Strain: GalacticHaze License#: QA#: 210123BS001Type: Flower HarvestDate: Unknown

ApprovedBy: N.Mosely,CEOAddress:4920 Atlanta Highway DateofReceipt: 2021-01-23

Alpharetta, GA 30004 DateofTesting: 2021-01-23 S. Stevens,LDR

ChemicalResidueScreen-TestReport

Cannabissampleswerehomogenizedandextractedusingacustomprotocol.InstrumentalanalysiswasperformedwithUHPLC-MS/MS(tandemquadrupole).TargetcompoundswereidentifiedbymatchingtoCertifiedReferenceMaterials.Ion-selectivedetection(multiplereactionmonitoring,orMRM)wasusedtoensurethatprecursorandproductionsofthecorrectmassesco-elutedandwereobservedinratiosmatchingthoseforthereferencematerials.

Dozensofcompoundsrepresentingmanydifferentclassesoffungicides,herbicides,andplantgrowthregulatorswerescreenedfor.ThisdocumentlistsallanalytesdetectedintheChemicalResidueScreen.

Findings

AnalyteName CAS#AmountInSample PASS/FAIL

WAStateActionLevel

(sum)Spinosads NA NOTDETECTED PASS 0.20ppm(sum)Permethrins NA NOTDETECTED PASS 0.20ppmCarbaryl 63-25-2 0.062ppm PASS 0.20ppmAbamectinB1a 71751-41-2 NOTDETECTED PASS 0.50ppmAcephate 30560-19-1 NOTDETECTED PASS 0.40ppmAcetamiprid 135410-20-7 NOTDETECTED PASS 0.20ppmAldicarb 116-06-3 NOTDETECTED PASS 0.40ppmAzoxystrobin 131860-33-8 NOTDETECTED PASS 0.20ppmBifenazate 149877-41-8 NOTDETECTED PASS 0.20ppmBifenthrin 82657-04-3 NOTDETECTED PASS 0.20ppmBoscalid 188425-85-6 NOTDETECTED PASS 0.40ppmCarbofuran 1563-66-2 NOTDETECTED PASS 0.20ppmChlorantraniliprole 500008-45-7 NOTDETECTED PASS 0.20ppmChlormequat 7003-89-6 NOTDETECTED PASS 0.10ppmChlorpyrifos 2921-88-2 NOTDETECTED PASS 0.20ppmcis-Permethrin 52645-53-1 NOTDETECTED PASS 0.20ppmClofentezine 74115-24-5 NOTDETECTED PASS 0.20ppmDaminozide 1596-84-5 NOTDETECTED PASS 1.00ppm

AnalyteName CAS#AmountInSample PASS/FAIL

WAStateActionLevel

Diazinon 333-41-5 NOTDETECTED PASS 0.20ppmDichlorvos 62-73-7 NOTDETECTED PASS 0.10ppmDimethoate 60-51-5 NOTDETECTED PASS 0.20ppmEthoprophos 13194-48-4 NOTDETECTED PASS 0.20ppmEtofenprox 80844-07-1 NOTDETECTED PASS 0.40ppmEtoxazole 153233-91-1 NOTDETECTED PASS 0.20ppmFenoxycarb 72490-01-8 NOTDETECTED PASS 0.20ppmFenpyroximate 134098-61-6 NOTDETECTED PASS 0.40ppmFipronil 120068-37-3 NOTDETECTED PASS 0.40ppmFlonicamid 158062-67-0 NOTDETECTED PASS 1.00ppmFludioxonil 131341-86-1 NOTDETECTED PASS 0.40ppmHexythiazox 78587-05-0 NOTDETECTED PASS 1.00ppmImazalil 35554-44-0 NOTDETECTED PASS 0.20ppmImidacloprid 138261-41-3 NOTDETECTED PASS 0.40ppmKresoxim-methyl 143390-89-0 NOTDETECTED PASS 0.40ppmMalathion 121-75-5 NOTDETECTED PASS 0.20ppmMetalaxyl 57837-19-1 NOTDETECTED PASS 0.20ppmMethiocarb 2032-65-7 NOTDETECTED PASS 0.20ppm

*Greaterthanlowerlimitofdetection(>LLOD)andlessthanlowerlimitofquantification(<LLOQ).Appliestoinstanceswhentheanalytehasbeendetectedandpositivelyidentified,buttheconcentrationislowerthanwecanaccuratelyquantify.Specifically:signaltonoiseratiogreaterthan3andsignallessthancalibration.LLODis~0.001ppmformostanalytes,LLOQis~0.01formostanalytes.Numbershownislowerendofcalibration(LLOQ).

**Greaterthanupperlimitofquantification(>ULOQ).Appliestoinstanceswhentheanalyteconcentrationinthesampleisgreaterthanwecanaccuratelymeasurewithoutadditionaltesting.Numbershownisupperendofcalibration(ULOQ).

ThesetestingresultsarecertifiedbyscientificexaminationofasinglesampleprovidedbytheProducer/Processor.ConfidenceAnalyticsanditsagentsdidnotobserveorparticipateinthesampleselectionprocess,andcannotconfirmtheauthenticityofthesampleoritsrepresentativenessoftheassociatedlot/batch.Thesample,asreceived,washomogenizedbeforesubsamples

weredrawnforspecificanalyses.Thisreportissupplementaltoanyotherreportswiththesameanalyticsamplenumber.

Page 6: Official Test Results for Laboratory Sample # 7111625

THCmax(a.k.a.TotalTHC)=d9-THC+(THC-A*0.877)CBDmax(a.k.a.TotalCBD)=CBD+(CBD-A*0.877)

TotalCannabinoidisarawsumofallmeasuredcannabinoidsInTraceability,TotalCannabinoidisasumofTHCmaxandCBDmax

Figuresmaydifferslightlyfromtraceabilityduetorounding

ND=NotDetectedNE=NotExamined

Unk=Unknown

AnalyticalMethodsUsedCannabinoids:HPLC-UVMicrobial:PlateCountingTerpenes:HS-GC-FIDSolvents:HS-GC-MS

TraceResidue:UHPLC-MSMS

WaterActivity:HYGROMER®Page4of4

OfficialTestResultsforLaboratorySample#8012382Origination:Apothecary Rx UBI#: Inventory#: 210123BS001

Strain: GalacticHaze License#: QA#: 210123BS001Type: Flower HarvestDate: Unknown

ApprovedBy: N.Mosely,CEOAddress:4920 Atlanta Highway DateofReceipt: 2021-01-23

Alpharetta, GA 30004 DateofTesting: 2021-01-23 S. Stevens,LDR

ChemicalResidueScreen-TestReport

Cannabissampleswerehomogenizedandextractedusingacustomprotocol.InstrumentalanalysiswasperformedwithUHPLC-MS/MS(tandemquadrupole).TargetcompoundswereidentifiedbymatchingtoCertifiedReferenceMaterials.Ion-selectivedetection(multiplereactionmonitoring,orMRM)wasusedtoensurethatprecursorandproductionsofthecorrectmassesco-elutedandwereobservedinratiosmatchingthoseforthereferencematerials.

Dozensofcompoundsrepresentingmanydifferentclassesoffungicides,herbicides,andplantgrowthregulatorswerescreenedfor.ThisdocumentlistsallanalytesdetectedintheChemicalResidueScreen.

Findings

AnalyteName CAS#AmountInSample PASS/FAIL

WAStateActionLevel

Methomyl 16752-77-5 NOTDETECTED PASS 0.40ppmMyclobutanil 88671-89-0 NOTDETECTED PASS 0.20ppmNaled 300-76-5 NOTDETECTED PASS 0.50ppmOxamyl 23135-22-0 NOTDETECTED PASS 1.00ppmPaclobutrazol 76738-62-0 NOTDETECTED PASS 0.40ppmPhosemet(Imidan) 732-11-6 NOTDETECTED PASS 0.20ppmPiperonylButoxide 51-03-6 NOTDETECTED NA NAPrallethrin 23031-36-9 NOTDETECTED PASS 0.20ppmPropiconazole 60207-90-1 NOTDETECTED PASS 0.40ppmPropoxur 114-26-1 NOTDETECTED PASS 0.20ppmPyrethrinI 8003-34-7 NOTDETECTED NA NAPyridaben 96489-71-3 NOTDETECTED PASS 0.20ppmSpinosadA 168316-95-8 NOTDETECTED PASS 0.20ppmSpinosadD 168316-95-9 NOTDETECTED PASS 0.20ppmSpiromesifen 283594-90-1 NOTDETECTED PASS 0.20ppmSpirotetramat 203313-25-1 NOTDETECTED PASS 0.20ppmSpiroxamine 118134-30-8 NOTDETECTED PASS 0.40ppmTebuconazole 80443-41-0 NOTDETECTED PASS 0.40ppm

AnalyteName CAS#AmountInSample PASS/FAIL

WAStateActionLevel

Thiacloprid 111988-49-9 NOTDETECTED PASS 0.20ppmThiamethoxam 153719-23-4 NOTDETECTED PASS 0.20ppmtrans-Permethrin 52645-53-2 NOTDETECTED PASS 0.20ppmTrifloxystrobin 141517-21-7 NOTDETECTED PASS 0.20ppmUniconazole 83657-22-1 NOTDETECTED PASS 0.10ppm

*Greaterthanlowerlimitofdetection(>LLOD)andlessthanlowerlimitofquantification(<LLOQ).Appliestoinstanceswhentheanalytehasbeendetectedandpositivelyidentified,buttheconcentrationislowerthanwecanaccuratelyquantify.Specifically:signaltonoiseratiogreaterthan3andsignallessthancalibration.LLODis~0.001ppmformostanalytes,LLOQis~0.01formostanalytes.Numbershownislowerendofcalibration(LLOQ).

**Greaterthanupperlimitofquantification(>ULOQ).Appliestoinstanceswhentheanalyteconcentrationinthesampleisgreaterthanwecanaccuratelymeasurewithoutadditionaltesting.Numbershownisupperendofcalibration(ULOQ).

ThesetestingresultsarecertifiedbyscientificexaminationofasinglesampleprovidedbytheProducer/Processor.ConfidenceAnalyticsanditsagentsdidnotobserveorparticipateinthesampleselectionprocess,andcannotconfirmtheauthenticityofthesampleoritsrepresentativenessoftheassociatedlot/batch.Thesample,asreceived,washomogenizedbeforesubsamples

weredrawnforspecificanalyses.Thisreportissupplementaltoanyotherreportswiththesameanalyticsamplenumber.

Page 7: Official Test Results for Laboratory Sample # 7111625

R&D

Medicine Creek Analytics Certificate of Analysis

3700 Pacific HWY E, Ste 400, Fife, WA 98424WA State I502 Certification 0018 | ISO 17025 91428 | Accreditation #91428

Sample: 8012382 #COC/INVOICE: 4082

Laboratory ID 210124-006 Matrix Flower Batch ID Inventory ID

Tested for Confidence Analytics Address 14797 NE 95th St Redmond, WA 98052 License 3

Received 01/25/2021 Reported 01/28/2021

Analyses executed MET

MET - Heavy Metals Detection AnalysisAnalyzed Jan 28, 2021 | Instrument ICP-MS

AnalyteLOD

ug/5gLOQ

ug/5gResultug/5g

WRLug/5g

AnalyteLOD

ug/5gLOQ

ug/5gResultug/5g

WRLug/5g

Arsenic (As) 0.02 0.06 10 Cadmium (Cd) 0.01 0.04 ND 4.1

Lead (Pb) 0.01 0.02 ND 6 Mercury (Hg) 0.02 0.07 ND 2

NR Not ReportedND Not Detected<LOD Below Lod NT Not TestedLOD Limit of DetectionLOQ Limit of QuantificationDET Detected below quantitation limitCFU/g Colony Forming Units per 1 gramTNTC Too Numerous to Countmg/g Milligrams per gramppm Parts per million WRL Washington Regulatory Limit

Authorized Signature

Kyle Shelton Lab Manager01/28/2021

*This report shall not be reproduced except in full, without the written approval of the lab. This report is for informational purposesonly and should not be used to diagnose, treat or prevent any disease. Results are only for samples and batches indicated.Measurement uncertainties available upon request. Reporting limits available upon request. Results are valid for 6 months fromdate reported, unless otherwise indicated.

210124-006 page 1 of 1

ND